Kongressthemen Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance and Commercialisation Path to Improve Clinical Decision-Making and Patient Outcomes
The 13th Clinical Biomarkers and CDx Europe 2023 returns as the premier European forum for end-to-end discussions, actionable insights, and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress toward commercialisation.
Speakers: Agata Baczynska, Head of Diagnostic Alliance Management, AstraZeneca, Alix Berton, VP, Head of Disease Understanding and Precision Biomarkers, Bayer, and more